IMARC Group, a leading market research company, has recently releases report titled “Human Microbiome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global human microbiome market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the human microbiome market?
The global human microbiome market size reached US$ 679.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,058.5 Million by 2028, exhibiting a growth rate (CAGR) of 19.5% during 2023-2028.
Request for a sample report or buy full report: https://www.imarcgroup.com/human-microbiome-market/requestsample
What is human microbiome?
The human microbiome refers to the collection of microorganisms, including bacteria, viruses, fungi, and other microbes, that reside on and within the human body. It plays a crucial role in maintaining human health and is found in various areas such as the skin, mouth, gut, and reproductive organs. The human microbiome is an intricate ecosystem of microorganisms coexisting in symbiosis with the human host, playing a crucial role in maintaining health and overall well-being. The human microbiome encompasses various regions of the body, such as the skin, mouth, gut, and reproductive organs, each harboring distinct microbial populations.
The microbiome has the ability to recover and regain balance after disturbances such as antibiotic treatments or dietary changes. It also helps in the digestion and metabolism of dietary components, such as complex carbohydrates and fiber, producing beneficial metabolites like short-chain fatty acids.
What are the growth prospects and trends in the ambulance services industry?
The global market is primarily driven by the growing demand for microbiome-based products and therapies that can modulate the microbial composition to promote health and treat various disorders. In line with this, continual technological advancements in sequencing technologies and bioinformatics facilitating comprehensive profiling and analysis to develop targeted interventions and therapies.
Moreover, the rising prevalence of chronic diseases, such as obesity, diabetes, gastrointestinal disorders, and autoimmune conditions, is resulting in extensive research and development (R&D) activities focusing on the therapeutic potential of the human microbiome. Additionally, the integration of microbiome research into precision medicine for the development of personalized treatments and interventions is creating a positive market outlook.
Key Market Segmentation:
The report has segmented the global human microbiome market on the basis of product, application, disease type and region.
Breakup by Product:
- Probiotics
- Prebiotics
- Diagnostic Tests
- Drugs
- Medical Food
- Others
Breakup by Application:
- Therapeutics
- Diagnostics
Breakup by Disease Type:
- Obesity
- Diabetes
- Autoimmune Disorders
- Cancer
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- 4D pharma plc
- Atlas Biomed Group Limited
- BIOHM
- BiomX
- Bione
- DayTwo Inc.
- ENTEROME
- Ferring B.V.
- Finch Therapeutics
- Second Genome Inc.
- SynBioBeta LLC
- Synthetic Biologics Inc.
- Vedanta Biosciences Inc.
- Viome Inc.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4420&flag=C
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: https://twitter.com/ImarcServices
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/